^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    mipetresgene autoleucel (TBI-1301)

    i
    Other names: TBI-1301, NY-ESO-1 antigen-specific T- cell therapy, NY-ESO-1 antigen-specific RetroNectin TCR gene therapy, NY-ESO-1 antigen-specific TCR-gene-transduced autologous lymphocytes, TCR-gene-transduced autologous lymphocytes, TBI 1301, TCR gene transduced autologous lymphocytes, RetroNectin TCR gene therapy, NY-ESO-1 siTCR, TBI-1301-A
    Company:
    Takara
    Drug class:
    TCR modulator, NY ESO 1 inhibitor
    Related drugs: